Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors, antagonists |
Mechanism Tubulin inhibitors, VEGFR2 antagonists(Vascular endothelial growth factor receptor 2 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC22H23ClN4O |
InChIKeyGVYILVRBAJBRKS-UHFFFAOYSA-N |
CAS Registry1392817-26-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | - | - | |
Neoplasms | Preclinical | - | - | |
Neoplasms | Preclinical | - | - |